Sin un ganador y sin saber todavía qué partido controlará
Read moreSin presidente todavía, el futuro de la salud también sigue siendo incierto
Home » Medications »
Enhertu Approved in the U.S. for the Treatment of Patients With Previously Treated HER2 Positive Advanced Gastric Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE) January 15,
Read moreModerna Confirms Supply Agreement with the Ministry of Health to Supply Singapore with mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 14, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology
Read morePfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors
NEW YORK–(BUSINESS WIRE) November 23, 2020 — Pfizer Inc. (NYSE:
Read moreSecond Interim Analysis of Clinical Trial Data Showed a 91.4% Efficacy for the Sputnik V Vaccine on Day 28 After the First Dose; Vaccine Efficacy is Over 95% 42 days After the First Dose
The efficacy of the Sputnik V vaccine is 91.4%, based
Read morePfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness
NEW YORK, 16 November 2020 — Pfizer (NYSE: PFE) today announced the U.S. COVID-19
Read moreBristol Myers Squibb Announces Deucravacitinib (BMS-986165) Demonstrated Superiority to Placebo and Otezla® (apremilast) in Pivotal Phase 3 Psoriasis Study
PRINCETON, N.J.–(BUSINESS WIRE) November 3, 2020 — Bristol Myers Squibb
Read moreNIH Begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19
October 16, 2020 — The National Institutes of Health has
Read moreMerck Presents Three-Year Survival Data for Keytruda (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With Keytruda in Advanced Non‑Small Cell Lung Cancer
KENILWORTH, N.J.–(BUSINESS WIRE) October 16, 2020 — Merck (NYSE: MRK),
Read moreVaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., (NASDAQ:
Read more